Silencing of LASP-1 by RNAi in highly LASP-1 expressing human breast and ovarian cancer cells led to reduced cell proliferation, migration and to cell cycle arrest in G2-phase [19,20]. This evidence concerns the gene LASP1 and ovarian carcinoma.